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Comparison of Chronic Wound Care Products
(Last modified October 2008)
Chronic wounds most commonly include pressure ulcers (also called decubitus ulcers or bed sores), diabetic foot ulcers, burns, and varicose ulcers. They are
generally difficult to heal and are often resistant to treatment.1 Most pressure ulcers occur in the lower part of the body. The elderly and bedridden spinal cord
injury patients are prone to chronic wounds. Common complications of skin ulcers include osteomyelitis, sepsis, and death.1 Measures to prevent pressure ulcers
include recognizing patients at risk, reducing bed rest, reducing constant pressure, assessing and maintaining nutritional status, and preserving skin integrity.
Treatment is based on the extent of the wound.2 Staging of ulcers and other chronic wounds is a common practice and relates to wound depth. A stage 1 wound is
identified by nonblanchable redness of intact skin. Stage 2 is characterized by ulcer extension through the epidermis or dermis. Stage 3 ulcers extend through the
full thickness of the skin into the subcutaneous tissue and create a crater. Stage 4 effects include tissue necrosis with muscle, bone, or underlying structural damage.3
During the healing process, wounds progress through three, sometimes overlapping, phases: the inflammatory phase (redness, heat, swelling, pain), the proliferative
phase (migration of fibroblasts into the wound, cellular proliferation, granulation, angiogenesis), and the maturation phase (new collagen production and deposition,
migration of epithelial cells).4 Treatment of chronic wounds involves provision of moisture and occlusion, prevention and treatment of infections (several wound
care lines include products with silver ions for antimicrobial activity), and debridement (the removal of necrotic or fibrous tissue).2,4 Surgical debridement is
recommended for patients with sepsis or advancing cellulitis. Autolytic and chemical (enzymatic) debridement take weeks and can be used in less severe cases.4
Autolytic debridement, which occurs through retention of natural wound fluids, isn’t good for infected or very deep wounds.4 This chart reviews products used for
the treatment of chronic wounds, including antimicrobials, debriding agents, dressings, and wound cleansers.
Agent
General Indications*
Cost of Selected
Comments
Products**
Alginate Dressings

Calcium alginate
(AlgiDERM, Curasorb [also
available in Canada], Sorbsan, etc)
Available as ropes or pads

•
•
•
•
•
•
•
•

Abrasions/lacerations/skin
tears
Arterial ulcers
Deep and tunneling wounds
Diabetic ulcers
Donor sites
Pressure ulcers
Second degree burns
Venous ulcers

Varies, as
different shapes
and sizes of
dressings are
available
Around $50 for
a ten-pack of
dressings [U.S.]

•
•
•
•

Absorbs wound exudate and forms a gel-like covering
to facilitate autolytic debridement and maintenance of
a moist wound environment.5
Good for moderately to heavily exudative wounds
and hemorrhagic wounds.2,5,6
Can leave in place until soaked with exudate.2
Requires a secondary dressing.5

Around $7 per
dressing
[Canada]
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General Indications*

Agent

Cost of Selected
Products**

Comments

Enzymatic Debridement

Papain, Urea
(Accuzyme, EtheZyme, etc)
Available as foam, ointment, or
spray

Papain, Urea,
Chlorophyllin Copper Complex
(Panafil, Ziox, etc)
Available as ointment or spray
Collagenase ointment
(Santyl)

•
•
•
•

Burn eschar
Diabetic foot ulcer
Pressure ulcer, stage 2 to 4
Varicose ulcer

UPDATE (9/23/08): FDA instructs
manufacturers to stop marketing
topical papain-containing products
due to reports of serious
hypersensitivity reactions
associated with their use. Patients
with latex sensitivity may be at
increased risk. These products have
never been approved by the FDA.14

•
•
•
•

Burn eschar
Diabetic foot ulcer
Pressure ulcer, stage 2 to 4
Varicose ulcer

$54.55
30 gm tube
($1.81/gm)

•
•
•

•
$88.00
30 gm tube
($2.93/gm)
$74.24
30 gm tube
($2.47/gm)

•
•
•
•
•
•

Trypsin, Castor Oil,
Peru Balsam
(Granulex, Xenaderm)
Available as gel, ointment, or
spray

•
•
•

Burn eschar
Pressure ulcer, stage 1 to 4
Varicose ulcer

$19.41
113 gm spray
($0.17/gm)
$61.90
30 gm tube
($2.06/gm)

•
•
•
•
•
•

Papain is a proteolytic enzyme that debrides necrotic,
nonviable tissue.4
Urea supplements papain by exposing sulfhydryl
groups in necrotic tissue to papain’s action.4
Chlorophyllin copper complex inhibits
hemagglutination and inflammatory properties of
protein degradation products. It promotes healthy
granulation, reduces inflammation, and reduces odor.4
Panafil can be used continuously to promote wound
healing.7
Avoid peroxide or heavy metal (e.g. mercury, silver)
containing agents as they inactivate papain.4
Can be used for infected wounds.4
Collagenase is specific for digestion of collagen in
necrotic tissue.4
Can be used for infected wounds.4
Optimal pH for enzymatic action is 6 to 8; avoid
acidic agents for cleansing.
Peroxide does not affect its efficacy, but avoid
detergents and heavy metal (e.g. mercury, silver)
containing agents.4
The only debriding agent covered by Medicare.
Trypsin is a mild debriding agent.
Castor oil and Peru Balsam are protectants. Peru
Balsam reduces wound odor.
Can be used for infected wounds.4
May not be better than mechanical gauze
debridement.1,8
Avoid concurrent use of silver-containing agents
because they can reduce efficacy.

More. . .
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General Indications*

Agent

Cost of Selected
Products**

Comments

Foams

Hydrophilic polyurethane foam
(Biopatch, Curafoam, Flexzan, etc)

•
•
•
•
•
•
•

Absorptive secondary
dressing for packed wounds
Diabetic ulcers, pressure
ulcers, and venous stasis
ulcers
Donor sites
Draining surgical incisions
Granulation tissue
Superficial burns
Tube and drain sites

Price varies
depending on
dressing size
Between $30
and $70 for a
ten-pack of
dressings

•
•
•
•
•

Moderately to highly absorbent, semi-occlusive
dressing. Maintains a moist wound environment and
absorbs exudate.2,5
Good for chronic wounds that are granulating.6 Good
for cavitating wounds.5
Some require a secondary dressing. Some may be
used as a secondary dressing.5
Change dressing every three to four days.2,5
May promote development of malodorous drainage.2

Hydrocolloids and Hydrogels

Carboxymethylcellulose
dressings, granules, patches, and
paste
(Aquacel, Curaderm, DuoDerm
CGF [also available in Canada],
etc)

Hydrogels
(Curasol, Carrasyn [also available
in Canada], Nu-Gel, Tegaderm
[also available in Canada], etc)
Also available as sheets
(Flexderm, Vigilon, FlexiGel, etc)
and gauze (Biolex, Curafil, etc)

•
•
•
•

Cuts and abrasions
First and second degree
burns
Pressure ulcers
Stasis ulcers

Depends on
size
$20.50 for a
five-pack of
dressings
Around $4.75
per dressing
[Canada]
$18.62 for
90 gm of
Carrasyn gel
($0.21/gm)
Depends on
size of dressing
$5 to $10 per
dressing
Around $5 per
dressing
[Canada]

•
•
•
•
•
•

•

Used to keep a wound moist and absorb exudate,
while autolytically debriding the wound.5
Not for wounds that are producing moderate to heavy
exudate. Not for infected wounds.5
Hydrocolloids and hydrogels may provide pain
relief.2
These products must be covered by a secondary
dressing.5
Hydrocolloids can develop a foul odor after two to
four days, which can be mistaken for infection.2,6
Hydrocolloids are good for chronic wounds that are
epithelializing.6 They are considered semi-occlusive
moisture retentive dressings and can be left in place
for up to seven days or until fluid leaks.2
Hydrogels are good for chronic wounds that are
debriding.6 They are good for keeping a dry wound
moist.5 Hydrogels can be left in place for one to three
days.2

More. . .
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General Indications*

Agent

Cost of Selected
Products**

Comments

Hydrofibers

Carboxymethylcellulose fiber
(Aquacel, Aquacel AG)

•
•
•
•
•
•
•

Burns
Diabetic foot ulcers
Donor sites
Infected wounds
Leg ulcers
Pressure ulcers
Surgical wounds

•

Chronic nonhealing,
exuding wounds such as
pressure or leg ulcers and
exuding, infected wounds

Around $5.00
to $15.00 per
dressing
depending on
size

•

$101.60
40 gm gel
($2.54/gm)

•

•
•

Exudate absorber. Good for wounds with heavy
exudate. Good for mild hemostasis.4,5
Can be left in place until soaked with exudate.2
Needs to be held in place by a secondary dressing.5

Iodine Compounds

Cadexomer Iodine
Available as a gel (Iodosorb)
or as a dressing, ointment, or
powder (Iodoflex [also available in
Canada])

•

$15.95
10 gm gel
($1.59/gm)
[Canada]

•
•

Around $8 per
5”x5” dressing

•

Varies
depending on
size

•

Absorbs exudate and debris, releases iodine for
antimicrobial activity.2
Change the dressing when it turns white, showing that
the iodine has been depleted.9
Requires use of a secondary dressing.9
Contraindicated in patients with iodine sensitivity,
Hashimoto’s thyroiditis, nontoxic nodular goiter, and
in children.9
Potential risk of interaction with systemic lithium.9

Moisture Vapor Permeable Films

Bioclusive, CarraFilm, Tegaderm
HP, etc.

•
•
•
•
•

Autolytic debridement
facilitated by the moist
wound healing environment
Clean, closed surgical
incisions
Skin graft donor sites
Stage 1 or 2 pressure ulcers
Second-degree burns

Tegaderm
4”x4.75”
dressings are
about
$1.50 each

•
•
•
•
•
•
•

Waterproof, but semi-permeable to passage of oxygen
and water vapor to and from the wound.5
Nonabsorbant.2
Prevents wound desiccation and contamination by
bacteria.5
Promotes autolysis of necrotic tissue in the wound,
maintains a moist environment, helps retain growth
factors in the wound bed.5
Good secondary dressings to hold a primary dressing
in place. Can also be used as primary dressing.2,5
Leave on for up to seven days or until fluid leaks.2
May provide pain relief.2
Reserve for wounds with minimal exudate.2
More. . .
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General Indications*

Agent

Cost of Selected
Products**

Comments

Regrowth Stimulants

Becaplermin gel, rh-PDGF
(Regranex)

•

Diabetic foot ulcer
(extending into the
subcutaneous tissue or
beyond)

$724.98
15 gm tube
($48.33/gm)

•

•
•
Phenytoin
(Dilantin, generics [also available
in Canada])
Prepared as a suspension of the
contents of a 100 mg capsule
mixed with 5 mL sterile saline or
powder applied directly to wound

•
•
•
•

Burn eschar***
Diabetic foot ulcer***
Pressure ulcer, stage 2***
Varicose ulcer***

$34.84
100 capsules
(generic)
($0.35/capsule)
$7.69
100 capsules
($0.77/capsule)
[Canada]

•

•

Becaplermin is a recombinant formulation of plateletderived growth factor (rh-PDGF) which promotes cell
mitogenesis and protein synthesis for granulation
tissue formulation.2
Adequate blood supply to the affected area and the
absence of necrotic tissue are needed for efficacy.2
Repeated use of Regranex (3 or more tubes) may
increase the risk of cancer-related death. Use with
caution in patients with known malignancy.10
Phenytoin may stimulate proliferation of fibroblasts,
enhance granulation tissue, decrease wound exudate,
promote collagen deposition, and decrease bacterial
contamination.11,13
Topical phenytoin appears to be effective and safe for
healing soft tissue wounds.11-13 [Evidence level A;
quantitative systematic review]13

Topical Antibiotics

Bacitracin, Neomycin,
Polymyxin B
(Neosporin, generics [also
available in Canada])
Available as ointment or cream
Bacitracin, Polymyxin B
(Polysporin, generics)
Available as an ointment

•

Prevention or treatment of
superficial infection

$6.36
30 gm tube
(generic)
($0.21/gm)

•
•
•
•

Ointment dosage forms are difficult to remove.
May have cytotoxic effects that could delay wound
healing.
Allergic reactions may occur.
Bacteria may become resistant with prolonged use.

$6.78
30 gm tube
(generic)
($0.23/gm)
$5.47
15 gm tube
($0.36/gm)
[Canada]
More. . .
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General Indications*

Agent

Cost of Selected
Products**

Comments

Topical Antibiotics, continued

Gentamicin
(Garamycin, generics [also
available in Canada])
Available as ointment or cream

Silver sulfadiazine cream
(Silvadene, SSD, Dermazin
[Canada])

•

•
•

Prevention or treatment of
superficial skin and soft
tissue infections due to
susceptible gram-negative
and gram-positive
organisms.

Prevention of infection in
second- and third-degree
burns
Prevention or treatment of
infection in chronic
wounds***

$3.60
15 gm tube
(generic)
($0.24/gm)
$4.28
3.5 gm tube
($1.22/gm)
[Canada]

$14.68
1% 85 gm jar
(generic)
($0.17/gm)
$10.07
50 gm
($0.20/gm)
[Canada]

•
•
•
•

•
•
•
•

Ointment dosage forms are difficult to remove.
May have cytotoxic effects that could delay wound
healing.
Allergic reactions may occur.
Bacteria may become resistant with prolonged use.

May have cytotoxic effects that could delay wound
healing.
Allergic reactions may occur.
Bacteria may become resistant with prolonged use.
Do not use with collagenase, papain, or trypsincontaining enzymatic debriding agents.4

Wound Cleansers

Sterile saline
(Normal saline for irrigation 0.9%)

•

General wound cleaning
and rinsing

$14.16
1000 mL

•
•

$2.73
1000 mL
[Canada]
•

Best for general wound cleaning and rinsing.
Note: avoid other wound cleaners such as povidone
iodine (Betadine), chlorhexidine gluconate
(Hibiclens), hypochlorite solution (Dakin’s solution),
benzalkonium chloride solution, acetic acid solution.
They can disturb granulation tissue and be cytotoxic
if not diluted or used too vigorously.1
Hydrogen peroxide 3% solution may delay healing
but 20% solution acts as a healing enhancer.1

More. . .
Copyright © 2008 by Therapeutic Research Center
Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249
www.pharmacistsletter.com ~ www.prescribersletter.com

(Detail-Document #240511: Page 7 of 8)

General Indications*

Agent

Cost of Selected
Products**

Comments

Wound Cleansers, continued

Around
Water, surfactant, salt solutions
• General wound cleaning
• Some contain moisturizing agents.5
(Allclenz, Biolex, Dermagran [also
$1/30 mL
and rinsing
available in Canada], UltraKlenz,
etc)
* Information is from U.S. product labeling.
** Cost information is approximate as of the time this chart was prepared. It is based on average wholesale price (AWP). Actual selling prices may
differ.
*** non-FDA approved indication

Users of this document are cautioned to use their own professional judgment and consult any other necessary or appropriate sources prior to making clinical
judgments based on the content of this document. Our editors have researched the information with input from experts, government agencies, and national
organizations. Information and Internet links in this article were current as of the date of publication.
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Levels of Evidence

4.

In accordance with the trend towards Evidence-Based
Medicine, we are citing the LEVEL OF EVIDENCE
for the statements we publish.

5.

Level
A

B

C
D

Definition
High-quality randomized controlled trial (RCT)
High-quality meta-analysis (quantitative
systematic review)
Nonrandomized clinical trial
Nonquantitative systematic review
Lower quality RCT
Clinical cohort study
Case-control study
Historical control
Epidemiologic study
Consensus
Expert opinion
Anecdotal evidence
In vitro or animal study

6.

7.
8.

9.

10.

Adapted from Siwek J, et al. How to write an evidence-based clinical
review article. Am Fam Physician 2002;65:251-8.

Project Leader in preparation of this DetailDocument: Joseph A. Woelfel, Ph.D., FASCP,
R.Ph., Assistant Editor (Original January 2006);
Stacy Hester, R.Ph., BCPS, Assistant Editor (May
2008 update)
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